Back
Agree Realty Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
49
ADC
Agree Realty
Last Price:
61.45
Seasonality Move:
1.68%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
49
Agree Realty (ADC)
is a Sell
Is Agree Realty a Buy, Sell or Hold?
- The current Agree Realty [ADC] share price is $61.22. The Score for ADC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- ADC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADC Stock Price Chart
What is Agree Realty's stock price today?
-
The Agree Realty share price today is $61.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADC is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $38.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
ADC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 57.76 | Buy |
| Chaikin Money Flow: | -333073 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.74 - 61.38) | Buy |
| Bollinger Bands (100): | (56.24 - 60.02) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 40.05 | Sell |
| Chaikin Money Flow: | 76134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.06 - 42.34) | Sell |
| Bollinger Bands (100): | (41.13 - 48.85) | Sell |
ADC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.87 | Buy |
| 20-day SMA: | 60.58 | Buy |
| 50-day SMA: | 59.12 | Buy |
| 200-day SMA: | 58.43 | Buy |
| 8-day EMA: | 61.11 | Buy |
| 20-day EMA: | 60.66 | Buy |
| 50-day EMA: | 59.62 | Buy |
| 200-day EMA: | 59.82 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.68 | Sell |
| 20-day SMA: | 40.48 | Sell |
| 50-day SMA: | 42.18 | Sell |
| 200-day SMA: | 42.45 | Sell |
| 8-day EMA: | 39.81 | Sell |
| 20-day EMA: | 40.64 | Sell |
| 50-day EMA: | 42.13 | Sell |
| 200-day EMA: | 43.5 | Sell |
Agree Realty Earnings Growth & ADC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.02 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Agree Realty Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||